Company Filing History:
Years Active: 2024
Title: The Innovations of David Chirgwin
Introduction
David Chirgwin is an accomplished inventor based in Watertown, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of formulations of modified peripheral blood mononuclear cells (PBMCs). His work has the potential to impact therapeutic applications significantly.
Latest Patents
David Chirgwin holds a patent for formulations of PBMCs. This patent provides formulations that include PBMCs comprising at least one antigen, such as a human papillomavirus (HPV) antigen, along with a cryopreservation medium. In certain embodiments, the PBMCs are conditioned by incubating them in the presence of an adjuvant, enhancing their effectiveness.
Career Highlights
Chirgwin is associated with Stemcell Technologies Canada Inc., where he applies his expertise in developing innovative solutions for cell-based therapies. His work at the company has positioned him as a key player in advancing research in this critical area of medicine.
Collaborations
Some of his notable coworkers include Howard Bernstein and Scott Loughhead. Their collaboration fosters a dynamic environment for innovation and research, contributing to the success of their projects.
Conclusion
David Chirgwin's contributions to the field of biomedical research through his patent on PBMC formulations exemplify his commitment to innovation. His work continues to pave the way for advancements in therapeutic applications.